Valeant Pharmaceuticals
An update on recent developments released by Valeant Pharmaceuticals
Published in Healthcare Mergers, Acquisitions and Ventures Week, May 26th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Valeant Pharmaceuticals.
Report 1: Valeant Pharmaceuticals International (VRX) announced that it is developing an intranasal form of delivery for diazepam for the treatment of seizure emergencies in children and adults, in conjunction with researchers from the University of Minnesota.
Valeant currently markets Diastat AcuDial (diazepam rectal gel), a U.S. Food and Drug Administration (FDA)-approved at-home treatment for the acute management of increased seizure...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- AARP
AARP Rolls Up Their Sleeves Nationwide, Gives Back to Local Communities - Abbott
Abbott Highlights Strong Performance in Corporate Social Responsibility in 2006 Global Citizenship Report - Abraxis BioScience, Inc.
Abraxis BioScience Reports First Quarter 2007 Revenue of $212.2 Million Versus $144.5 Million in Prior Year Period - Abt Associates
Abt Associates' Richard A. Kulka Elected President-elect of American Association for Public Opinion Research - Abt Associates
Constantin Abarbieritei To Lead Abt Associates' International Economic Growth Division - Acambis
Ian Garland joins Acambis as new CEO - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
